![](/img/cover-not-exists.png)
A multicenter, open-label, randomized study comparing the efficacy of atorvastatin versus usual care in reducing refractory hypercholesterolemia in high-risk patients to target levels
Gilbert Habib, François Paillard, Guillaume Charpentier, Jean-François Angellier, Thierry Roux, Jean-Jacques Portal, Pascal MaigretVolume:
61
Year:
2000
Language:
english
DOI:
10.1016/s0011-393x(00)89032-3
File:
PDF, 1.07 MB
english, 2000